Judy Savitskaya

Judy Savitskaya, a partner at Andreessen Horowitz specializing in synthetic biology, joins to discuss groundbreaking research that seeks to revolutionize photosynthesis. The conversation dives into a synthetic chloroplast combining natural and artificial elements to enhance carbon fixation and improve crop efficiency. Savitskaya explores the inefficiencies of the Rubisco enzyme and innovative strategies for overcoming its limitations. The use of microfluidics in experimentation adds a fascinating layer to their discussion on the future of agricultural biotechnology.

Vijay Pande, a general partner at Andreessen Horowitz with a focus on biotechnologies, joins Judy Savitskaya, a bio deal partner specializing in virology. They delve into groundbreaking machine learning methods for antibiotic discovery, particularly the novel antibiotic Halicin. The conversation reveals the potential to combat antibiotic resistance. Savitskaya also shares insights on the coronavirus structures, linking them to past SARS research and discussing their implications for vaccine development and viral entry mechanisms.

Julie Yoo, a general partner at Andreessen Horowitz with a focus on healthcare technology, and Judy Savitskaya, a bio partner at the same firm, dive into the U.S. healthcare system's response to COVID-19. They discuss the complexities of patient management and the pivotal role technology plays in enhancing care. Highlights include decoding the rt-PCR test and addressing misconceptions about pandemics versus epidemics. Their insights shed light on how accurate data can shape public understanding during health crises.